1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Catheter Introducer Sheath Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Catheter Introducer Sheath Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter’s Five Force Analysis
5.2. List of Major Brands of Large (>16F) Catheter Introducer Sheath and its Comparative Pricing
5.3. List of Major Large (>16F) Introducer Sheath Manufacturer/Suppliers
5.4. Key Countries Market Value (US$ Mn) for Large (>16F) Catheter Introducer Sheath, 2017-2031
6. Global Catheter Introducer Sheath Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Integrated Introducer Sheaths
6.3.2. Separate Introducer Sheaths
6.4. Market Attractiveness Analysis, by Product Type
7. Global Catheter Introducer Sheath Market Analysis and Forecast, by French Size
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by French Size, 2017-2031
7.3.1. > 16F
7.3.1.1. Cardiovascular
7.3.1.2. Peripheral Vascular
7.3.1.3. Neurovascular
7.3.1.4. Others
7.3.2. 16F-10F
7.3.2.1. Cardiovascular
7.3.2.2. Peripheral Vascular
7.3.2.3. Neurovascular
7.3.2.4. Others
7.3.3. <10F
7.3.3.1. Cardiovascular
7.3.3.2. Peripheral Vascular
7.3.3.3. Neurovascular
7.3.3.4. Others
7.4. Market Attractiveness Analysis, by French Size
8. Global Catheter Introducer Sheath Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Catheter Introducer Sheath Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Catheter Introducer Sheath Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Integrated Introducer Sheaths
10.2.2. Separate Introducer Sheaths
10.3. Market Value Forecast, by French Size, 2017-2031
10.3.1. > 16F
10.3.1.1. Cardiovascular
10.3.1.2. Peripheral Vascular
10.3.1.3. Neurovascular
10.3.1.4. Others
10.3.2. 16F-10F
10.3.2.1. Cardiovascular
10.3.2.2. Peripheral Vascular
10.3.2.3. Neurovascular
10.3.2.4. Others
10.3.3. <10F
10.3.3.1. Cardiovascular
10.3.3.2. Peripheral Vascular
10.3.3.3. Neurovascular
10.3.3.4. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By French Size
10.6.3. By End-user
10.6.4. By Country
11. Europe Catheter Introducer Sheath Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Integrated Introducer Sheaths
11.2.2. Separate Introducer Sheaths
11.3. Market Value Forecast, by French Size, 2017-2031
11.3.1. > 16F
11.3.1.1. Cardiovascular
11.3.1.2. Peripheral Vascular
11.3.1.3. Neurovascular
11.3.1.4. Others
11.3.2. 16F-10F
11.3.2.1. Cardiovascular
11.3.2.2. Peripheral Vascular
11.3.2.3. Neurovascular
11.3.2.4. Others
11.3.3. <10F
11.3.3.1. Cardiovascular
11.3.3.2. Peripheral Vascular
11.3.3.3. Neurovascular
11.3.3.4. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By French Size
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Catheter Introducer Sheath Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Integrated Introducer Sheaths
12.2.2. Separate Introducer Sheaths
12.3. Market Value Forecast, by French Size, 2017-2031
12.3.1. > 16F
12.3.1.1. Cardiovascular
12.3.1.2. Peripheral Vascular
12.3.1.3. Neurovascular
12.3.1.4. Others
12.3.2. 16F-10F
12.3.2.1. Cardiovascular
12.3.2.2. Peripheral Vascular
12.3.2.3. Neurovascular
12.3.2.4. Others
12.3.3. <10F
12.3.3.1. Cardiovascular
12.3.3.2. Peripheral Vascular
12.3.3.3. Neurovascular
12.3.3.4. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By French Size
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Catheter Introducer Sheath Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Integrated Introducer Sheaths
13.2.2. Separate Introducer Sheaths
13.3. Market Value Forecast, by French Size, 2017-2031
13.3.1. > 16F
13.3.1.1. Cardiovascular
13.3.1.2. Peripheral Vascular
13.3.1.3. Neurovascular
13.3.1.4. Others
13.3.2. 16F-10F
13.3.2.1. Cardiovascular
13.3.2.2. Peripheral Vascular
13.3.2.3. Neurovascular
13.3.2.4. Others
13.3.3. <10F
13.3.3.1. Cardiovascular
13.3.3.2. Peripheral Vascular
13.3.3.3. Neurovascular
13.3.3.4. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By French Size
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Catheter Introducer Sheath Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Integrated Introducer Sheaths
14.2.2. Separate Introducer Sheaths
14.3. Market Value Forecast, by French Size, 2017-2031
14.3.1. > 16F
14.3.1.1. Cardiovascular
14.3.1.2. Peripheral Vascular
14.3.1.3. Neurovascular
14.3.1.4. Others
14.3.2. 16F-10F
14.3.2.1. Cardiovascular
14.3.2.2. Peripheral Vascular
14.3.2.3. Neurovascular
14.3.2.4. Others
14.3.3. <10F
14.3.3.1. Cardiovascular
14.3.3.2. Peripheral Vascular
14.3.3.3. Neurovascular
14.3.3.4. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of the MEA
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By French Size
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Boston Scientific Corporation
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Stryker Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Teleflex Incorporated
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Merit Medical Systems, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Terumo Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Medtronic plc
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. W. L. Gore & Associates, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Becton, Dickinson, and Company (BD)
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Cardinal Health, Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. B. Braun SE
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. ICU Medical, Inc.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview
15.3.14. Cook Medical
15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.14.2. Product Portfolio
15.3.14.3. Financial Overview
15.3.14.4. SWOT Analysis
15.3.14.5. Strategic Overview
15.3.15. BIOTRONIK SE & Co KG
15.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.15.2. Product Portfolio
15.3.15.3. Financial Overview
15.3.15.4. SWOT Analysis
15.3.15.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
